Fredun Pharmaceuticals Limited has submitted a regulatory disclosure to BSE Limited regarding its upcoming earnings conference call. The disclosure is made pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will host an Earnings Conference Call for the first quarter of fiscal year 2027 (Q1 FY27) on Thursday, 13th August, 2026 at 11:30 a.m.
Conference Call Details:
- Registration Link: Provided as "CLICK HERE FOR REGISTRATION"
- Dial-In Numbers: +91 22 6280 1239 and +91 22 7115 8140
- Recommendation: Participants are advised to dial in 10 minutes prior to the conference schedule
Management Representation:
The conference call will feature speakers from management, including Fredun Nariman Medhora, Managing Director (DIN: 01745348), who digitally signed the disclosure document on August 8, 2026, at 19:11:10 IST.
Disclaimer:
The document includes a standard disclaimer stating that the management will not be responsible for any action taken based on statements and discussions during the conference call.
Additional Information:
The disclosure is addressed to BSE Limited's Listing Department at Phiroze Jeejeebhoy Towers, Dalal Street - Fort, Mumbai - 400 001.